Journal article

Itraconazole or Amphotericin B for Talaromycosis. - Author Reply

Abstract:: Giovane et al inquired whether the treatment effects differed on the basis of disease severity or preexisting medical conditions. First, we caution that criteria for severe disease have not been defined for talaromycosis. Second, international guidelines recommending itraconazole for mild to moderate disease and amphotericin B for severe disease are based solely on expert opinions and case series.

Publication status:: Published

Peer review status:: Reviewed (other)

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Le, T., Thwaites, G., & Wolbers, M. (2017). Itraconazole or Amphotericin B for Talaromycosis. - Author Reply. New England Journal of Medicine, 377(14), 1403.

MLA Style

Le, T, et al. “Itraconazole or Amphotericin B for Talaromycosis. - Author Reply.” New England Journal of Medicine, vol. 377, no. 14, 2017, p. 1403.

Chicago Style

Le, T, G Thwaites, and M Wolbers. 2017. “Itraconazole or Amphotericin B for Talaromycosis. - Author Reply.” New England Journal of Medicine 377 (14): 1403.
Print

Access Document

Files:: Author reply in IVAP trial_NEJM 2017.pdf

(Preview, Version of record, pdf, 66.0KB, Terms of use)

Publisher copy:: 10.1056/nejmc1709123

Authors

+ Le, T More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDM
Sub department:: Tropical Medicine
Role:: Author

+ Thwaites, G More by this author

Institution:: University of Oxford
Division:: Medical Sciences Division
Department:: NDM; Tropical Medicine
Role:: Author

+ Wolbers, M More by this author

Role:: Author

Publisher:: Massachusetts Medical Society
Journal:: New England Journal of Medicine More from this journal
Volume:: 377
Issue:: 14
Pages:: 1403
Publication date:: 2017-10-01
Acceptance date:: 2017-08-31
DOI:: 10.1056/nejmc1709123
EISSN:: 1533-4406
ISSN:: 0028-4793
Pmid:: 28976858

Language:: English
Keywords:: Aspergillosis

Itraconazole

Antifungal Agents

Amphotericin B
Pubs id:: pubs:732859
UUID:: uuid:4d961914-f931-427a-8925-ddbde58d272e
Local pid:: pubs:732859
Source identifiers:: 732859
Deposit date:: 2017-11-15
ARK identifier:: ark:/29072/ora_4d961914f931427a8925ddbde58d272e

Terms of use

Copyright holder:: Massachusetts Medical Society
Copyright date:: 2017
Notes:: Copyright © 2017 Massachusetts Medical Society. All rights reserved. This is the published version of the article. This version is also available online from the Massachusetts Medical Society at: http://dx.doi.org/10.1056/nejmc1709123

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP